Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Making LDL Matter Again: Addressing Clinical, Patient, and Payer Barriers in ASCVD Management : Episode 8
Reinstating LDL-C Targets
Panelists discuss how reinstating LDL-C targets in quality programs could improve outcomes and accountability.
EP: 1.Understanding the Current State of LDL-C Goal Attainment and Barriers to Adequate Control in Hyperlipidemia
EP: 2.Challenges with Undertreatment in Hyperlipidemia and Opportunities to Address this Gap
EP: 3.Pharmacy-Driven Challenges
EP: 4.Real-World Insights and PROMPT-LIPID
EP: 5.Social Determinants of Health
EP: 6.The 2013 Guideline Shift
EP: 7.Unintended Consequences of Metric Changes
Now Viewing
EP: 8.Reinstating LDL-C Targets
Panelists discuss how reinstating low-density lipoprotein cholesterol (LDL-C) targets could realign quality programs toward outcomes-driven care. Setting measurable goals encourages clinicians to intensify therapy and monitor progress.
They emphasize that outcomes-based incentives could harmonize payer and provider priorities, fostering accountability across systems. Restoring LDL-C targets may also reduce variability and close treatment gaps by making success measurable.
The discussion underscores that combining statin adherence metrics with LDL-C goal attainment could produce the most balanced and impactful framework.
Related Videos
Related Content
